Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	New Amedeo service: Amedeo COVID-19 (formerly 2019-nCoV) Weekly publication summary

Tuberculosis

Free Subscription 01.01.2020 2 Am J Respir Crit Care Med 4 Antimicrob Agents Chemother 1 BMJ 3 Clin Infect Dis 3 Emerg Infect Dis 1 Eur J Clin Microbiol Infect Dis 3 Eur Respir J 1 Infect Immun 11 Int J Tuberc Lung Dis 1 J Bacteriol 2 J Immunol 1 Lancet 4 Lancet Infect Dis 14 PLoS One

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Am J Respir Crit Care Med

1. YOON C, Semitala FC, Cattamanchi A
   Reply to Parker: Implications of Tuberculosis Sputum Culture Test Sensitivity on Accuracy of Other Diagnostic Modalities.
   Am J Respir Crit Care Med. 2019;199:665.
   PubMed     Text format    
   
   
2. PARKER RA
   Implications of Tuberculosis Sputum Culture Test Sensitivity on Accuracy of Other Diagnostic Modalities.
   Am J Respir Crit Care Med. 2019;199:664.
   PubMed     Text format    
   
   

   
   Antimicrob Agents Chemother

3. BJUGARD NYBERG H, Draper HR, Garcia-Prats AJ, Thee S, et al
   Population pharmacokinetics and dosing of ethionamide in children with tuberculosis.
   Antimicrob Agents Chemother. 2019 Dec 23. pii: AAC.01984.
   PubMed     Text format     Abstract available
   
   
4. KWARA A, Yang H, Antwi S, Enimil A, et al
   Effect of rifampin/isoniazid-containing antituberculosis therapy on efavirenz pharmacokinetics in HIV-infected children aged 3 to 14 years old.
   Antimicrob Agents Chemother. 2018 Nov 5. pii: AAC.01657.
   PubMed     Text format     Abstract available
   
   
5. ABDELWAHAB MT, Leisegang R, Dooley KE, Mathad JS, et al
   Population Pharmacokinetics of Isoniazid, Pyrazinamide, and Ethambutol in South African Pregnant Women with Tuberculosis and HIV.
   Antimicrob Agents Chemother. 2019 Dec 16. pii: AAC.01978.
   PubMed     Text format     Abstract available
   
   
6. ELINGS W, Gaur A, Blok AJ, Timmer M, et al
   beta-Lactamase of Mycobacterium tuberculosis shows dynamics in the active site that increase upon inhibitor binding.
   Antimicrob Agents Chemother. 2019 Dec 23. pii: AAC.02025.
   PubMed     Text format     Abstract available
   
   

   
   BMJ

7. HAQUE AKM, Bagtharia R, Rawal J
   Acute paraplegia in a healthy child.
   BMJ. 2019;367:l6257.
   PubMed     Text format    
   
   

   
   Clin Infect Dis

8. BOGLIONE L, Lipani F, Lucchini AM, Salvador E, et al
   Antiviral therapy in patients with HBV treated for tuberculosis: a forgotten issue.
   Clin Infect Dis. 2019 Dec 17. pii: 5679635. doi: 10.1093/cid/ciz1199.
   PubMed     Text format    
   
   
9. ALFFENAAR JC, Heysell SK, Mpagama SG
   Therapeutic Drug Monitoring: The Need for Practical Guidance.
   Clin Infect Dis. 2019;68:1065-1066.
   PubMed     Text format    
   
   
10. NOLT D
    Granulomas and guidelines - the search for tuberculosis during TNF-alpha inhibition.
    Clin Infect Dis. 2019 Dec 4. pii: 5651255. doi: 10.1093/cid/ciz1139.
    PubMed     Text format    
    
    

    
    Emerg Infect Dis

11. LUIS BAL, Diaz-Lomeli P, Gomez-Albarran LP, Martinez-Gamboa A, et al
    Mycobacterium obuense Bacteremia in a Patient with Pneumonia.
    Emerg Infect Dis. 2019;25:1015-1016.
    PubMed     Text format     Abstract available
    
    
12. HIGGITT RL, Louis van Schalkwyk O, de Klerk-Lorist LM, Buss PE, et al
    Mycobacterium bovis Infection in African Wild Dogs, Kruger National Park, South Africa.
    Emerg Infect Dis. 2019;25:1425-1427.
    PubMed     Text format     Abstract available
    
    
13. BRODE SK, Chung H, Campitelli MA, Kwong JC, et al
    Prescribing Patterns for Treatment of Mycobacterium avium Complex and M. xenopi Pulmonary Disease in Ontario, Canada, 2001-2013.
    Emerg Infect Dis. 2019;25.
    PubMed     Text format     Abstract available
    
    

    
    Eur J Clin Microbiol Infect Dis

14. WEIGL JAI
    Open flanks in the management of tuberculosis in Germany under the pressure of migration.
    Eur J Clin Microbiol Infect Dis. 2019 Dec 17. pii: 10.1007/s10096-019-03791.
    PubMed     Text format     Abstract available
    
    

    
    Eur Respir J

15. STEK C, Allwood B, Du Bruyn E, Buyze J, et al
    The effect of HIV-associated tuberculosis, tuberculosis-IRIS, and prednisone on lung function.
    Eur Respir J. 2019 Dec 20. pii: 13993003.01692-2019.
    PubMed     Text format     Abstract available
    
    
16. DE VRIES G, Commandeur S, Erkens C, Haddad W, et al
    Towards selective tuberculosis screening of people in prison in a low-incidence country.
    Eur Respir J. 2019 Dec 20. pii: 13993003.02209-2019.
    PubMed     Text format    
    
    
17. JONSSON J, Kuhlmann-Berenzon S, Berggren I, Bruchfeld J, et al
    Increased risk of active tuberculosis during pregnancy and postpartum: a register-based cohort study in Sweden.
    Eur Respir J. 2019 Dec 20. pii: 13993003.01886-2019.
    PubMed     Text format     Abstract available
    
    

    
    Infect Immun

18. RUIZ-TAGLE C, Naves R, Balcells ME
    Unraveling the role of microRNAs in Mycobacterium tuberculosis infection and disease: advances and pitfalls.
    Infect Immun. 2019 Dec 23. pii: IAI.00649-19. doi: 10.1128/IAI.00649.
    PubMed     Text format     Abstract available
    
    

    
    Int J Tuberc Lung Dis

19. REIMANN M, Schaub D, Kalsdorf B, Runge C, et al
    Cigarette smoking and culture conversion in patients with susceptible and M/XDR-TB.
    Int J Tuberc Lung Dis. 2019;23:93-98.
    PubMed     Text format     Abstract available
    
    
20. AGIZEW T, Boyd R, Auld AF, Payton L, et al
    Treatment outcomes, diagnostic and therapeutic impact: Xpert vs. smear. A systematic review and meta-analysis.
    Int J Tuberc Lung Dis. 2019;23:82-92.
    PubMed     Text format     Abstract available
    
    
21. PEDRAZZOLI D, Borghi J, Viney K, Houben RMGJ, et al
    Measuring the economic burden for TB patients in the End TB Strategy and Universal Health Coverage frameworks.
    Int J Tuberc Lung Dis. 2019;23:5-11.
    PubMed     Text format     Abstract available
    
    
22. AGGERBECK H, Ruhwald M, Hoff ST, Tingskov PN, et al
    Interaction between C-Tb and PPD given concomitantly in a split-body randomised controlled trial.
    Int J Tuberc Lung Dis. 2019;23:38-44.
    PubMed     Text format     Abstract available
    
    
23. VAN DEUN A, Tahseen S, Affolabi D, Hossain MA, et al
    Sputum smear microscopy in the Xpert((R)) MTB/RIF era.
    Int J Tuberc Lung Dis. 2019;23:12-18.
    PubMed     Text format     Abstract available
    
    
24. HARRIES AD, Timire C, Takarinda KC, Sandy C, et al
    Ensuring that Xpert((R)) MTB/RIF is used to its maximum potential.
    Int J Tuberc Lung Dis. 2019;23:1043-1044.
    PubMed     Text format    
    
    
25. HARRIES AD, Chakaya JM
    Assessing and managing pulmonary impairment in those who have completed TB treatment in programmatic settings.
    Int J Tuberc Lung Dis. 2019;23:1044-1045.
    PubMed     Text format    
    
    
26. JINDAL SK
    Searching for a mole in the hill.
    Int J Tuberc Lung Dis. 2019;23:1047.
    PubMed     Text format    
    
    
27. TADYANEMHANDU C, Garvey C, Chin A, Metcalfe J, et al
    More should be done now for patients with TB-associated chronic lung disease.
    Int J Tuberc Lung Dis. 2019;23:1122-1123.
    PubMed     Text format    
    
    
28. DOWDY DW
    Implementation of Xpert((R)) MTB/RIF: real challenges, real promise.
    Int J Tuberc Lung Dis. 2019;23:1123.
    PubMed     Text format    
    
    
29. MISHRA B, Mohapatra PR
    Expand the RRDR hotspot to improve GeneXpert results.
    Int J Tuberc Lung Dis. 2019;23:1043.
    PubMed     Text format    
    
    

    
    J Bacteriol

30. SOLER-ARNEDO P, Sala C, Zhang M, Cole ST, et al
    Polarly localized EccE1 is required for ESX-1 function and stabilization of ESX-1 membrane proteins in Mycobacterium tuberculosis.
    J Bacteriol. 2019 Dec 16. pii: JB.00662-19. doi: 10.1128/JB.00662.
    PubMed     Text format     Abstract available
    
    

    
    J Immunol

31. HOOK JS, Cao M, Weng K, Kinnare N, et al
    Mycobacterium tuberculosis Lipoarabinomannan Activates Human Neutrophils via a TLR2/1 Mechanism Distinct from Pam3CSK4.
    J Immunol. 2019 Dec 23. pii: jimmunol.1900919. doi: 10.4049/jimmunol.1900919.
    PubMed     Text format     Abstract available
    
    
32. WONG EA, Evans S, Kraus CR, Engelman KD, et al
    IL-10 Impairs Local Immune Response in Lung Granulomas and Lymph Nodes during Early Mycobacterium tuberculosis Infection.
    J Immunol. 2019 Dec 20. pii: jimmunol.1901211. doi: 10.4049/jimmunol.1901211.
    PubMed     Text format     Abstract available
    
    

    
    Lancet

33. VARO R, Bila R, Saavedra B, Sitoe A, et al
    Paraplegia and spinal deformity in a Mozambican child with Pott's disease and tuberculous scrofula.
    Lancet. 2019;394:1651.
    PubMed     Text format    
    
    

    
    Lancet Infect Dis

34. ADEPOJU P
    Nigeria's widening tuberculosis gap.
    Lancet Infect Dis. 2020;20:29.
    PubMed     Text format    
    
    
35. CAMPBELL JR, Trajman A, Cook VJ, Johnston JC, et al
    Adverse events in adults with latent tuberculosis infection receiving daily rifampicin or isoniazid: post-hoc safety analysis of two randomised controlled trials.
    Lancet Infect Dis. 2019 Dec 19. pii: S1473-3099(19)30575.
    PubMed     Text format     Abstract available
    
    
36. TIBERI S, Migliori GB
    What is the best regimen to treat latent tuberculosis infection?
    Lancet Infect Dis. 2019 Dec 19. pii: S1473-3099(19)30627.
    PubMed     Text format    
    
    
37. BROGER T, Muyoyeta M, Kerkhoff AD, Denkinger CM, et al
    Tuberculosis test results using fresh versus biobanked urine samples with FujiLAM.
    Lancet Infect Dis. 2020;20:22-23.
    PubMed     Text format    
    
    

    
    PLoS One

38. BLANKLEY S, Gashu T, Ahmad B, Belaye AK, et al
    Lessons learned: Retrospective assessment of outcomes and management of patients with advanced HIV disease in a semi-urban polyclinic in Epworth, Zimbabwe.
    PLoS One. 2019;14:e0214739.
    PubMed     Text format     Abstract available
    
    
39. XU C, Li R, Shewade HD, Jeyashree K, et al
    Attrition and delays before treatment initiation among patients with MDR-TB in China (2006-13): Magnitude and risk factors.
    PLoS One. 2019;14:e0214943.
    PubMed     Text format     Abstract available
    
    
40. DUNCAN K, Sinanovic E
    A cost comparison analysis of paediatric intermediate care in a tertiary hospital and an intermediate care facility in Cape Town, South Africa.
    PLoS One. 2019;14:e0214492.
    PubMed     Text format     Abstract available
    
    
41. AGGARWAL AN, Agarwal R, Sehgal IS, Dhooria S, et al
    Adenosine deaminase for diagnosis of tuberculous pleural effusion: A systematic review and meta-analysis.
    PLoS One. 2019;14:e0213728.
    PubMed     Text format     Abstract available
    
    
42. SHEWADE HD, Gupta V, Satyanarayana S, Pandey P, et al
    Patient characteristics, health seeking and delays among new sputum smear positive TB patients identified through active case finding when compared to passive case finding in India.
    PLoS One. 2019;14:e0213345.
    PubMed     Text format     Abstract available
    
    
43. YANG J, Lee S, Oh S, Han S, et al
    The risk of active tuberculosis among individuals living in tuberculosis-affected households in the Republic of Korea, 2015.
    PLoS One. 2019;14:e0225744.
    PubMed     Text format     Abstract available
    
    
44. IZUDI J, Tamwesigire IK, Bajunirwe F
    Does completion of sputum smear monitoring have an effect on treatment success and cure rate among adult tuberculosis patients in rural Eastern Uganda? A propensity score-matched analysis.
    PLoS One. 2019;14:e0226919.
    PubMed     Text format     Abstract available
    
    
45. ARRIAGA MB, Torres NMC, Araujo NCN, Caldas SCC, et al
    Impact of the change in the antitubercular regimen from three to four drugs on cure and frequency of adverse reactions in tuberculosis patients from Brazil: A retrospective cohort study.
    PLoS One. 2019;14:e0227101.
    PubMed     Text format     Abstract available
    
    
46. CHAVES TORRES NM, Quijano Rodriguez JJ, Porras Andrade PS, Arriaga MB, et al
    Factors predictive of the success of tuberculosis treatment: A systematic review with meta-analysis.
    PLoS One. 2019;14:e0226507.
    PubMed     Text format     Abstract available
    
    
47. ORINA F, Mwangi M, Meme H, Kitole B, et al
    Intrinsic and extrinsic factors associated with sputum characteristics of presumed tuberculosis patients.
    PLoS One. 2019;14:e0227107.
    PubMed     Text format     Abstract available
    
    
48. ABONG J, Dalay V, Langley I, Tomeny E, et al
    Use of GeneXpert and the role of an expert panel in improving clinical diagnosis of smear-negative tuberculosis cases.
    PLoS One. 2019;14:e0227093.
    PubMed     Text format     Abstract available
    
    
49. FELLAG M, Loukil A, Saad J, Lepidi H, et al
    Translocation of Mycobacterium tuberculosis after experimental ingestion.
    PLoS One. 2019;14:e0227005.
    PubMed     Text format     Abstract available
    
    
50. FATIMA R, Yaqoob A, Qadeer E, Hinderaker SG, et al
    Measuring and addressing the childhood tuberculosis reporting gaps in Pakistan: The first ever national inventory study among children.
    PLoS One. 2019;14:e0227186.
    PubMed     Text format     Abstract available
    
    
51. KANVATIRTH P, Jeeves RE, Bacon J, Besra GS, et al
    Utilisation of the Prestwick Chemical Library to identify drugs that inhibit the growth of mycobacteria.
    PLoS One. 2019;14:e0213713.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Tuberculosis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: